Table of Content

1 Study Coverage
1.1 Intravenous (IV) Solutions Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Intravenous (IV) Solutions Market by Region
1.4.1 Global Intravenous (IV) Solutions Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Intravenous (IV) Solutions Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Intravenous (IV) Solutions Revenue by Players
2.1.1 Global Intravenous (IV) Solutions Revenue by Players (2019-2024)
2.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Intravenous (IV) Solutions Revenue in 2024
2.2 Global Intravenous (IV) Solutions Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Intravenous (IV) Solutions Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 ICU Medical Inc. (U.S.)
3.1.1 ICU Medical Inc. (U.S.) Information
3.1.2 ICU Medical Inc. (U.S.) Overview
3.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.1.4 ICU Medical Inc. (U.S.) Related Developments
3.2 B. Braun Melsungen AG (Germany)
3.2.1 B. Braun Melsungen AG (Germany) Information
3.2.2 B. Braun Melsungen AG (Germany) Overview
3.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.2.4 B. Braun Melsungen AG (Germany) Related Developments
3.3 Fresenius Kabi AG (Germany)
3.3.1 Fresenius Kabi AG (Germany) Information
3.3.2 Fresenius Kabi AG (Germany) Overview
3.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.3.4 Fresenius Kabi AG (Germany) Related Developments
3.4 Baxter (U.S.)
3.4.1 Baxter (U.S.) Information
3.4.2 Baxter (U.S.) Overview
3.4.3 Baxter (U.S.) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.4.4 Baxter (U.S.) Related Developments
3.5 Amanta Healthcare (India)
3.5.1 Amanta Healthcare (India) Information
3.5.2 Amanta Healthcare (India) Overview
3.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.5.4 Amanta Healthcare (India) Related Developments
3.6 Terumo Medical Corporation (Tokyo)
3.6.1 Terumo Medical Corporation (Tokyo) Information
3.6.2 Terumo Medical Corporation (Tokyo) Overview
3.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.6.4 Terumo Medical Corporation (Tokyo) Related Developments
3.7 Grifols S.A. (Spain)
3.7.1 Grifols S.A. (Spain) Information
3.7.2 Grifols S.A. (Spain) Overview
3.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue and Gross Margin (2019-2024)
3.7.4 Grifols S.A. (Spain) Related Developments
4 Market Size by Type
4.1 Global Intravenous (IV) Solutions Revenue by Type
4.2 Global Intravenous (IV) Solutions Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Intravenous (IV) Solutions Revenue by Application
5.2 Global Intravenous (IV) Solutions Market Size Growth by Application 2019-2024
6 Global Intravenous (IV) Solutions Market Insights
6.1 Global Intravenous (IV) Solutions Market Revenue 2019-2024
6.2 Global Intravenous (IV) Solutions Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Intravenous (IV) Solutions Market Size by Country
7.1.1 Americas Intravenous (IV) Solutions Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Intravenous (IV) Solutions Market Size by Country
8.1.1 Europe Intravenous (IV) Solutions Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Intravenous (IV) Solutions Market Size by Region
9.1.1 Asia Pacific Intravenous (IV) Solutions Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Intravenous (IV) Solutions Market Size by Country
10.1.1 Middle East and Africa Intravenous (IV) Solutions Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Intravenous (IV) Solutions Industry Trends
11.2 Intravenous (IV) Solutions Market Drivers
11.3 Intravenous (IV) Solutions Market Challenges
11.4 Intravenous (IV) Solutions Market Restraints
12 Intravenous (IV) Solutions Forecasted Market Size by Type
12.1 Global Intravenous (IV) Solutions Forecasted Revenue by Type
12.2 Global Intravenous (IV) Solutions Forecasted Market Size Growth by Type 2024-2030
13 Intravenous (IV) Solutions Forecasted Market Size by Application
13.1 Global Intravenous (IV) Solutions Forecasted Revenue by Application
13.2 Global Intravenous (IV) Solutions Forecasted Market Size Growth by Application 2024-2030
14 Global Intravenous (IV) Solutions Market Forecasts
14.1 Global Intravenous (IV) Solutions Market Revenue Forecasts 2024-2030
14.2 Global Intravenous (IV) Solutions Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Intravenous (IV) Solutions Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Intravenous (IV) Solutions Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Intravenous (IV) Solutions Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Intravenous (IV) Solutions Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer